Article Versions Notes

Fujimoto K, Ikeda S, Tabata E, Kaneko T, Sagawa S, Yamada C, Kumagai K, Fukushima T, Haga S, Watanabe M, et al. KRAS^G12C Inhibitor as a Treatment Option for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia. Cancers. 2024; 16(7):1327. https://doi.org/10.3390/cancers16071327

Fujimoto, Kazushi, Satoshi Ikeda, Erina Tabata, Taichi Kaneko, Shinobu Sagawa, Chieri Yamada, Kosumi Kumagai, Takashi Fukushima, Sanshiro Haga, Masayuki Watanabe, and et al. 2024. "KRAS^G12C Inhibitor as a Treatment Option for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia" Cancers 16, no. 7: 1327. https://doi.org/10.3390/cancers16071327

Fujimoto, K., Ikeda, S., Tabata, E., Kaneko, T., Sagawa, S., Yamada, C., Kumagai, K., Fukushima, T., Haga, S., Watanabe, M., Muraoka, T., Sekine, A., Baba, T., & Ogura, T. (2024). KRAS^G12C Inhibitor as a Treatment Option for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia. Cancers, 16(7), 1327. https://doi.org/10.3390/cancers16071327